INTRODUCTION: Among industrialized countries, endometrial cancer is a common malignancy with generally an excellent outcome. To personalize medicine, we ideally compile as much information as possible concerning patient prognosis prior to effecting an appropriate treatment decision. Endometrial cancer preoperative risk stratification (ENDORISK) is a machine learning-based computational Bayesian networks model that predicts lymph node metastasis and 5-year disease-specific survival potential with percentual probability. Our objective included validating ENDORISK effectiveness in our patient cohort, assessing its application in the current use of sentinel node biopsy, and verifying its accuracy in advanced stages. METHODS: The ENDORISK model was evaluated with a retrospective cohort of 425 patients from the University Hospital Brno, Czech Republic. Two hundred ninety-nine patients were involved in our disease-specific survival analysis; 226 cases with known lymph node status were available for lymph node metastasis analysis. Patients were included undergoing either pelvic lymph node dissection (N = 84) or sentinel node biopsy (N =70) to explore the accuracy of both staging procedures. RESULTS: The area under the curve was 0.84 (95% confidence interval [CI], 0.77-0.9) for lymph node metastasis analysis and 0.86 (95% CI, 0.79-0.93) for 5-year disease-specific survival evaluation, indicating quite positive concordance between prediction and reality. Calibration plots to visualize results demonstrated an outstanding predictive value for low-risk cancers (grades 1-2), whereas outcomes were underestimated among high-risk patients (grade 3), especially in disease-specific survival. This phenomenon was even more obvious when patients were subclassified according to FIGO clinical stages. CONCLUSIONS: Our data confirmed ENDORISK model's laudable predictive ability, particularly among patients with a low risk of lymph node metastasis and expected favorable survival. For high-risk and/or advanced stages, the ENDORISK network needs to be additionally trained/improved.

Department of Data Science University of Twente Enschede Netherlands

Department of Gynecology and Obstetrics University Hospital Brno and Faculty of Medicine Masaryk University Brno Czechia

Department of Obstetrics and Gynecology Radboud University Medical Center Nijmegen Netherlands

Department of Pathology University Hospital Brno and Faculty of Medicine Masaryk University Brno Czechia

Department of Radiation Oncology Radboud University Medical Center Nijmegen Netherlands

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czechia

Zobrazit více v PubMed

Sant M, Lopez MDC, Agresti R, Sánchez Pérez MJ, Holleczek B, Bielska-Lasota M, et al. . Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study. Eur J Cancer. (2015) 51(15):2191–205. doi: 10.1016/j.ejca.2015.07.022 PubMed DOI

Salani R, Khanna N, Frimer M, Bristow RE, Chen LM. An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of gynecologic oncology (SGO) recommendations. Gynecol Oncol (2017) 146(1):3–10. doi: 10.1016/j.ygyno.2017.03.022 PubMed DOI

Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. . ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc (2021) 31(1):12–39. doi: 10.1136/ijgc-2020-002230 PubMed DOI

ASTEC study group. Kitchener H, Swart AMC, Qian Q, Amos C, Parmar MKB. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet Lond Engl (2009) 373(9658):125–36. doi: 10.1016/S0140-6736(08)61766-3 PubMed DOI PMC

Benedetti Panici P, Basile S, Maneschi F, Lissoni AA, Signorelli M, Scambia G, et al. . Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst (2008) 100(23):1707–16. doi: 10.1093/jnci/djn397 PubMed DOI

Frost JA, Webster KE, Bryant A, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev (2017) 10(10):CD007585. doi: 10.1002/14651858.CD007585.pub4 PubMed DOI PMC

Reijnen C, Gogou E, Visser NCM, Engerud H, Ramijith J, van der Putten LJM, et al. . Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study. PloS Med (2020) 17(5):e1003111. doi: 10.1371/journal.pmed.1003111 PubMed DOI PMC

Trovik J, Wik E, Werner HMJ, Krakstad C, Helland H, Vandenput I, et al. . Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. Eur J Cancer (2013) 49(16):3431–41. doi: 10.1016/j.ejca.2013.06.016 PubMed DOI

Visser NCM, Bulten J, van der Wurff AAM, Boss EA, Bronkhorst CM, Feijen HWH, et al. . PIpelle prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort study. BMC Cancer (2015) 15:487. doi: 10.1186/s12885-015-1487-3 PubMed DOI PMC

Cancer survival in England - adults diagnosed - office for national statistics. Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/cancersurvivalratescancersurvivalinenglandadultsdiagnosed (Accessed February 28, 2022).

Cong R, Kong F, Ma J, Li Q, Wu Q, Ma X. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer. BMC Cancer (2020) 20(1):464. doi: 10.1186/s12885-020-06953-8 PubMed DOI PMC

Dong Y, Cheng Y, Tian W, Zhang H, Wang Z, Li X, et al. . An externally validated nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer. Front Oncol (2019) 9:1218. doi: 10.3389/fonc.2019.01218. PubMed DOI PMC

Jiang P, Jia M, Hu J, Huang Z, Deng Y, Hu Z. A nomogram model involving immunohistochemical markers for predicting the recurrence of stage i-ii endometrial cancer (2021) (Accessed April 9, 2022). PubMed PMC

Jiang P, Huang Y, Tu Y, Li N, Kong W, Di F, et al. . Combining clinicopathological parameters and molecular indicators to predict lymph node metastasis in endometrioid type endometrial adenocarcinoma. Front Oncol (2021) 11:682925. doi: 10.3389/fonc.2021.682925. PubMed DOI PMC

Zheng T, Yang L, Du J, Dong Y, Wu S, Shi Q, et al. . Combination analysis of a radiomics-based predictive model with clinical indicators for the preoperative assessment of histological grade in endometrial carcinoma. Front Oncol (2021) 11:582495. doi: 10.3389/fonc.2021.582495. PubMed DOI PMC

Weinberger V, Bednarikova M, Hausnerova J, Ovesna P, Vinklerova P, Minar L, et al. . A novel approach to preoperative risk stratification in endometrial cancer: the added value of immunohistochemical markers. Front Oncol (2019) 9:265. doi: 10.3389/fonc.2019.00265 PubMed DOI PMC

Pineda VG, Zapardiel I, Gracia M, Siegrist J, Diestro MD, Alonso M, et al. . Avoiding full lymphadenectomies in intermediate- and high-risk endometrial cancer by sentinel lymph node biopsy implementation. Front Oncol (2021) 11:654285. doi: 10.3389/fonc.2021.654285 PubMed DOI PMC

Abu-Rustum NR, Gomez JD, Alektiar KM, Soslow RA, Hensley ML, Leitao MM, Jr., et al. . The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecol Oncol (2009) 115(2):236–8. doi: 10.1016/j.ygyno.2009.07.016 PubMed DOI

Faria SC, Devine CE, Rao B, Sagebiel T, Bhosale P. Imaging and staging of endometrial cancer. Semin Ultrasound CT MR. (2019) 40(4):287–94. doi: 10.1053/j.sult.2019.04.001 PubMed DOI

Liro M, Śniadecki M, Wycinka E, Wojtylak S, Brzeziński M, Stańczak A, et al. . Ultrasound measurement of tumor-free distance from the serosal surface as the alternative to measuring the depth of myometrial invasion in predicting lymph node metastases in endometrial cancer. Diagn Basel Switz (2021) 11(8):1472. doi: 10.3390/diagnostics11081472 PubMed DOI PMC